Press Room
As a global leader specializing in in vitro diagnostics for medical and industrial applications, bioMérieux is pleased to share information with members of the media.
bioMérieux in the Press
- How Labs Can Bolster Antimicrobial Stewardship
- CIO Applications: Hospitals Rely on New Technologies to Strengthen Patient Care
- Managed Healthcare Executive Discusses New CMS Rule and the Role of Diagnostics in Antimicrobial Stewardship Programs
- Triangle Business Journal Highlights Impact of new CMS Rules on AMR, Hospitals, and bioMérieux
- bioMérieux in the Press: 360Dx
-
-
-
Recent Press Releases & News
- bioMérieux: BIOFIRE® Respiratory 2.1 (RP2.1) Panel with SARS-CoV-2 Obtains De Novo FDA Authorization
- Innovative Technology Mitigates the Risk of Life-Threatening Toxins in Cannabis
- Cannabis and Hemp are Safer for Consumers with New Microbial Testing Method Validations
- bioMérieux Awarded First-ever COVID-19-Related AOAC Emergency Response Validation for its VERIPRO® SARS-CoV-2 Environmental Assay
- bioMérieux, Inc. Receives Nine AOAC Approvals in November
- bioMérieux Announces CLARION™ Infectious Diseases and Diagnostics Software
- View More >
Americas Leadership Team
- General Media
- Liza Deckelbaum
- 919-645-0782
- lizad@thestoneagency.com